receptors was detected by RT-PCR in mouse duodenal epithelium and SCBN cells, a duodenal epithelial cell line. UTP, a P2Y 2-receptor agonist, but not ADP (10 M), significantly induced murine duodenal short-circuit current and DMBS in vitro; these responses were abolished by suramin (300 M), a P2Y-receptor antagonist, or 2-aminoethoxydiphenyl borate (2-APB; 100 M), a store-operated channel blocker. Mucosal or serosal addition of UTP induced a comparable DMBS in wild-type mice, but markedly impaired response occurred in P2Y 2 knockout mice. Acid-stimulated DMBS in vivo was significantly inhibited by suramin (1 mM) or PPADS (30 M (30 M) , SK&F96365 (30 M), and 2-APB (10 M) inhibited UTP-induced Ca 2ϩ entry by 92, 87, and 94%, respectively. Taken together, our results imply that activation of P2Y2 receptors enhances DMBS via elevation of [Ca 2ϩ ]cyt that likely results from an initial increase in intracellular Ca 2ϩ release followed by extracellular Ca 2ϩ entry via store-operated channel.
P2Y2 receptor; cytoplasmic-free Ca 2ϩ ; capacitative Ca 2ϩ entry; storeoperated channels; duodenal ion transport PURINERGIC RECEPTORS (purinoceptors) are a family of widely expressed transmembrane receptors and are composed of two major classes based on their relative responses to adenosine and nucleotides (i.e., ATP, ADP, UTP, and UDP) (1) . P1 receptors are activated by adenosine, while nucleotides activate P2 receptors. P2 receptors are subdivided into ionotropic P2X receptors, which are ligand-gated channels, and metabotropic (G protein-coupled) P2Y receptors (39) . Activation of P2X receptors (P2X [1] [2] [3] [4] [5] [6] [7] and P2XM) increases the plasma membrane permeability to Na ϩ or Ca . P2Y receptors (P2Y 1 , P2Y 2 , P2Y 4 , P2Y 6 , P2Y 11 , P2Y 12 , P2Y 13 , and P2Y 14 ) classically signal mainly through G protein-dependent pathways, most commonly via G q -dependent pathways, activating phospholipase C (PLC) and mobilizing intracellular Ca 2ϩ (1, 39) . Purinergic receptors have been well characterized in many epithelial tissues, including the gastrointestinal tract, airway, and kidney (6, 10, 39) .
Both ATP and UTP are known to modulate electrolyte transport in the intestinal tract, pancreatic duct, and gallbladder (14, 24, 32, 40, 55) . The effects of ATP or UTP on epithelial Cl Ϫ , bicarbonate (HCO 3 Ϫ ), K ϩ secretion, and Na ϩ reabsorption have been studied extensively in mouse, rat, or guinea pig tissues and in cultured human cells (Caco-2, T84), mostly by the use of Ussing chambers (24, 28, 37, 39 -42, 54) . It has been demonstrated that P2Y receptors play an important role in regulating Cl Ϫ secretion in colon (24, 54) and HCO 3 Ϫ secretion in pancreatic duct and gallbladder epithelia (14, 32) . However, little is known about the expression and function of purinergic receptors in duodenum, in particular, their role in duodenal mucosal bicarbonate secretion (DMBS). Recently, duodenal brush-border intestinal alkaline phosphatase activity was reported to affect HCO 3 Ϫ secretion in rats (2), presumably by hydrolysis of endogenous luminal ATP. This finding implies that purinergic receptors are involved in the regulation of DMBS. Moreover, an increase in cytoplasmic-free Ca 2ϩ concentrations ([Ca 2ϩ ] cyt ) by P2 receptors is associated with intestinal epithelial ion and fluid secretion (39, 40) . An increase in [Ca 2ϩ ] cyt in duodenal epithelial cells elicits DMBS, which is a predominant physiological mechanism to defend gastric acid-induced duodenal injury (17, 20, 62 
MATERIALS AND METHODS
Animals. This study was approved by the University of California, San Diego Animal Subjects Committee. Female adult Harlan C-57 black mice, wild-type C57BL/6, and P2Y2 receptor knockout (backcrossed and inbred onto a C57BL/6 background) mice were housed in an animal care room with a 12:12-h light-dark cycle and were allowed free access to food and water. Our laboratory's use of P2Y 2-receptor knockout mice has been described previously (53) . Before each experiment, mice were deprived of food and water for at least 1 h, but for no longer than 90 min.
Ussing chamber experiments. Ussing chamber experiments were performed as described previously (19). Briefly, after mice were anesthetized with halothane and euthanized by cervical dislocation, the abdomen was opened by a midline incision. The proximal duodenum was removed and immediately placed in ice-cold isoosmolar mannitol and indomethacin (10 M) solution to suppress traumainduced release of prostaglandins. The duodenal tissue from each animal was stripped of seromuscular layers, divided, and examined in three chambers (window area, 0.1 cm 2 ). Experiments were performed under continuous short-circuited conditions (Voltage-Current Clamp, VCC 600; Physiological Instruments, San Diego, CA) with luminal pH maintained at 7.40 by continuous infusion of 5 mM HCl under the automatic control of a pH-stat system (ETS 822; Radiometer America, Westlake, OH). The volume of titrant infused per unit time was used to quantitate HCO 3 Ϫ secretion. Measurements were recorded at 5-min intervals, and mean values for consecutive 5-or 10-min periods were averaged. The rate of luminal HCO 3 Ϫ secretion was expressed as micromoles per centimeters squared per hour. The short-circuit current (Isc) was measured in microamperes and converted into microequivalents per centimeter squared per hour. After a 30-min period during which basal parameters were measured, inhibitors were added to both sides of the tissues for another 10 min, followed by addition of UTP or ADP to both sides of the tissues. Electrophysiological parameters and HCO 3 Ϫ secretion were then recorded for an additional 60 min. Acid-stimulated HCO 3 Ϫ secretion in vivo. In vivo experiments were performed using a well-validated technique, as described previously (27, 62) , with the HCO 3 Ϫ concentration of samples measured via a CO2-sensitive electrode. Mice were anesthetized by intraperitoneal injection of a Hypnorm/Midazolam cocktail (25% Hypnorm plus 25% Midazolam, 10 mg/kg). Respiratory rate and response to toe-pinch of the animals were carefully monitored. After initiation of anesthesia, the abdomen was opened, and the duodenum accessed through two small incisions: one just below the ribcage on the left side, and the other just below the sternum. The stomach was located through the first incision, and a small incision was made just proximal to the pyloric sphincter. A soft polyethylene catheter was inserted into the stomach through this incision, gently pushed through the pyloric sphincter, and tied firmly into position with silk suture thread around the outside of the pyloric sphincter, thus isolating the proximal duodenum (5-10 mm) from the stomach. The junction of the pancreatic duct and the duodenum was located through the incision below the sternum. A small incision was made in the duodenum, and a second polyethylene catheter was inserted and tied into place just proximal to the junction with the pancreatic duct without interrupting the duodenal blood supply. Thus pancreatic secretions were excluded from the test duodenal segment while the blood supply remained intact. Throughout the duration of the experiment, the duodenum maintained a healthy pink color and was kept moist within the abdominal cavity.
After surgery, the proximal duodenum was perfused (0.15 cc/min) with isotonic saline for 20 min. After this initial washout and recovery period, basal HCO 3 Ϫ secretion was measured for 20 min. The mouse was then given an intraperitoneal injection of drugs, as indicated by the experimental design or control vehicle (DMSO), and HCO 3 Ϫ secretion was measured for 6 min. The duodenal segment was then perfused with 10 mM HCl in isotonic saline for 5 min. After acidification, the segment was gently flushed to remove any residual acid and allowed a 5-min washout period. HCO 3 Ϫ secretion was then measured for an additional 42 min. After each experiment, the length of the duodenal test segment was measured in situ to the nearest millimeter. Animals could be sustained under these experimental conditions for Ͼ2 h. Sample volumes were measured by weight to the nearest 0.01 mg. The amount of HCO 3 Ϫ in the effluents was quantitated by use of a CO 2-sensitive electrode (Thermo Orion, Beverly, MA). The electrode was calibrated before each day's use by constructing a semilogarithmic standard curve using known HCO 3 Ϫ concentrations. A 1-ml aliquot from each 6-min perfusion period was individually sampled, yielding a reading in millivolts. This reading was then converted back to an HCO 3 Ϫ concentration, as dictated by the previously generated standard curve. In this way, HCO 3 Ϫ outputs were determined for each 6-min period and expressed as micromoles per centimeter per hour. Stimulated HCO 3 Ϫ outputs are presented as HCO 3 Ϫ output over time and as net HCO 3 Ϫ output (peak minus average basal output).
SCBN cell culture. SCBN, a canine duodenal epithelial cell line, was grown according to published methods (11, 12 ]cyt levels in SCBN cells were measured by fura 2 fluorescence ratio digital imaging, as described previously (62) . Briefly, SCBN cells, grown on coverslips, were loaded with 5 M fura 2-acetoxymethyl ester (AM) (dissolved in 0.01% Pluronic F-127 plus 0.1% DMSO in physiological salt solution described below) at room temperature for 50 min and then washed in normal physiological salt solution for at least 20 min. Thereafter, the coverslips with SCBN cells were mounted in a perfusion chamber on a Nikon microscope stage. Cells were initially superfused with physiological salt solution for 5 min and then switched to Ca 2ϩ -free or Ca 2ϩ solutions containing different drugs. The ratio of fura 2 fluorescence (510-nm light emission excited by 340-and 380-nm illuminations) from the cells, as well as background fluorescence, was collected at room temperature (22°C) with the use of a ϫ40 Nikon UV-Fluor objective and an intensified CCD camera (ICCD200). The fluorescence signals emitted from the cells were monitored continuously using a MetaFluor Imaging System (Universal Imaging, Downingtown, PA) and were recorded in an IBMcompatible computer for later analysis. [Ca 2ϩ ]cyt was calculated from fura 2 fluorescent emission excited at 340 and 380 nm using the ratio method based on the equation [Ca 2ϩ ]cyt ϭ Kd ϫ (Sf2/Sb2) ϫ (R Ϫ Rmin)/(Rmax Ϫ R), where Kd (225 nM) is the dissociation constant for Ca 2ϩ , R is the measured fluorescence ratio, and Rmin and Rmax are minimal and maximal ratios, respectively (25). Sf2/Sb2 is the fluorescence ratio for Ca 2ϩ -free and -bound indicators measured at 380 nm. RT-PCR analysis. Total RNA from SCBN cells or mouse duodenal mucosa was extracted with TRIzol reagent (Invitrogen, Carlsbad, CA), according to the manufacturer's instructions. Five micrograms of total RNA were converted into cDNA with reverse transcriptase. After inactivation at 70°C for 10 min, 1 l of the reaction mixture was incubated in buffer containing 0.2 mM dATP, dCTP, dGTP, and dTTP, 0.2 M oligonucleotide primers, as shown below, 3 mM MgCl2, 500 mM KCl, and a 10ϫ buffer consisting of 200 mM Tris ⅐ HCl (pH 8.0), together with 1 unit of Taq polymerase (Invitrogen). Primers were synthesized by Integrated DNA Technologies (Coralville, IA). Mouse P2Y2-specific sense and antisense primers (GenBank accession number is NM_008773) were 5Ј-AGCCCAT-TACGTGACTGTCC-3Ј and 5Ј-CTGAGGCAGGAAACAGGAAG-3Ј, respectively. Mouse P2Y4-specific sense and antisense primers (GenBank accession number is NM_020621) were 5Ј-AACCAG-GAAGCTGGGGTACT-3Ј and 5Ј-GGAGGTTCCTTAGGGT-CAGC-3Ј, respectively. Canine P2Y2-specific sense and antisense primers (GenBank accession number is XM_542321) were 5Ј-CGTCAACGTGGCTTACAAGA-3Ј and 5Ј-AATCCTCACTGCT-GGTGGAC-3Ј, respectively. Canine P2Y4-specific sense and antisense primers (GenBank accession number is XM_845543) were 5Ј-GTGCTACTCGCTGATGGTGA-3Ј and 5Ј-AAGCGGAGCAT-GAGGTAGAA-3Ј, respectively. GAPDH sense and antisense primers, as described by Ijichi et al. (29) , were 5Ј-ACCACAGTCCAT-GCCATCAC-3Ј and 5Ј-TCCACCACCCTGTTGCTGTA-3Ј, respectively. The samples were amplified in an automated thermal cycler (GeneAmp 2400; Applied Biosystems). DNA amplification conditions included an initial 3-min denaturation step at 94°C, 35 cycles of 30 s at 94°C, 30 s at 57°C, 40 s at 72°C, and a final elongation step of 10 min at 72°C. The products were electrophoresed on a 1.5% agarose gel, stained with ethidium bromide (0.5 g/ml), and then photographed under UV light.
Chemicals and solutions. UTP, ATP, ADP, SK&F96365, U-73122, nifedipine, suramin, and pyridoxal-phosphate-6-azo(benzene-2-4-disulphonic acid) tetrasodium salt (PPADS) were purchased from Sigma. 2-Aminoethoxydiphenyl borate (2-APB) was purchased from Tocris Bioscience (Ellisville, MO). Fura 2-AM was from Molecular Probes (Eugene, OR). The other chemicals were obtained from Fisher Scientific (Santa Clara, CA). The mucosal solution used in Ussing chamber experiments contained the following (in mM) and was bubbled with 100% O 2: 140 Na ϩ , 5. (10, 39) . We, therefore, attempted to identify these two subtypes of P2Y receptors in duodenal epithelial cells by using RT-PCR analysis. Figure 1 shows that transcripts for P2Y 2 were readily detected in both SCBN cells and mouse duodenal epithelium. P2Y 4 products were also detected in mouse duodenal epithelium at low levels. However, P2Y 4 products were undetectable in SCBN cells. Therefore, P2Y 2 is the main subtype of P2Y receptors expressed in duodenal epithelial cells.
UTP-induced murine duodenal ion transport in vitro.
Although expression of P2Y receptors and their role in regulating colonic Cl Ϫ secretion and HCO 3 Ϫ secretion from pancreatic ductal and gallbladder epithelia have been studied (14, 24, 32) , little is known about P2Y receptors in duodenal epithelial ion secretion. UTP selectively stimulates P2Y receptors (13, 52) , and thus we used it in Ussing chambers to test whether the P2Y receptors play a role in murine duodenal ion transport. In the first set of experiments, we studied the involvement of P2Y receptors and membrane ion channels in the duodenal epithelial ion transport by using pharmacological agents. As shown in Fig. 2 , after the baseline became stable for 30 min, addition of UTP (10 M) to the mucosal side of the chambers induced duodenal I sc ( Fig. 2A) . UTP (10 M) also stimulated duodenal HCO 3 Ϫ secretion, which reached a peak around 10 min later and lasted for at least 30 min. Therefore, we calculated net peak HCO 3 Ϫ secretion from the difference between the baseline and the peak value 10 min after addition of UTP (Fig. 2B) . Treatment of the duodenal tissues with suramin (300 M), a Fig. 1 . Expression of P2Y receptors in mouse duodenal epithelium and the SCBN cell line. Total RNA was isolated from mouse duodenal epithelium and SCBN cells. P2Y-receptor transcripts were detected by RT-PCR analysis. M, molecular weight marker; B, blank control in PCR reaction that contains all ingredients except cDNA. GAPDH was used as an internal loading control. These data are representative of 3 separate experiments with identical results. Fig. 2 . Effects of nucleotides on murine duodenal epithelial ion transport in vitro. A: time course of nucleotide-induced murine duodenal short-circuit current (Isc). After baseline was measured for 30 min, solvent or UTP (10 M) was added to the mucosal side of Ussing chambers, but ADP (10 M) was added to both sides, as indicated by an arrow. B: net peak duodenal bicarbonate (HCO 3 Ϫ ) secretion calculated from the difference between the baseline and the peak value at 10 min after addition of UTP (10 M) or ADP (10 M). In some experiments, the duodenal tissues were pretreated with suramin (300 M) or 2-aminoethoxydiphenyl borate (2-APB; 100 M) for 10 min before addition of UTP. Con, control. Values are mean Ϯ SE; n ϭ 5-6 for each group. **P Ͻ 0.01 vs. control. ##P Ͻ 0.01 vs. UTP alone. (Fig. 3A) . In a second set of experiments, we assessed the role of P2Y 2 receptors in mediating duodenal HCO 3 Ϫ secretion using a genetic approach. As Fig. 3B illustrates, UTP-stimulated HCO 3 Ϫ secretion was markedly impaired in P2Y 2 knockout mice compared with that in wild-type mice, even though carbachol-stimulated HCO 3 Ϫ secretion was similar in P2Y 2 knockout and wild-type mice. The latter results indicate that the capacity to respond to another G protein-coupled receptor, the muscarinic cholinergic receptor, is unaltered in the duodenal epithelium of P2Y 2 knockout animals. These data thus provide further evidence for the role of P2Y 2 receptors in mediating duodenal HCO 3 Ϫ secretion.
Involvement of P2Y receptors in acid-stimulated DMBS in vivo.
Our experiments conducted with Ussing chambers showed that the P2Y receptors are functionally expressed in murine duodenal epithelia and are involved in duodenal epithelial ion transport. To further investigate whether the P2Y receptors in duodenal epithelia have physiological roles, we measured acid-stimulated duodenal HCO 3 Ϫ secretion in whole animals. Figure 4A shows a time course study of HCl-stimulated murine DMBS in vivo. Duodenal luminal perfusion of HCl (10 mM) resulted in a robust increase in DMBS in control mice, which reached a maximal level at 30 min after acid stimulation and declined thereafter to the baseline level. Net peak HCO 3 Ϫ secretion, calculated from the difference between the baseline and the peak value at 30 min, was used to assess acid-stimulated HCO 3 Ϫ secretion (Fig. 4B) . Luminal perfusion of suramin (1 mM) significantly attenuated acid-stimulated DMBS; net peak HCO 3 Ϫ secretion was inhibited by 67% (Fig.  4) . PPADS (30 M), another P2Y-receptor antagonist with a chemical structure different from that of suramin (1), also attenuated acid-stimulated DMBS (Fig. 4A) ] cyt in SCBN cells by using a digital Ca 2ϩ imaging system. ATP (1 M) treatment in Ca 2ϩ -containing solutions markedly raised [Ca 2ϩ ] cyt , which consisted of a rapid rise to a peak, followed by rapid decline to a plateau phase that was relatively sustained until ATP was withdrawn (Fig. 5A) . In some instances, we observed oscillation in [Ca 2ϩ ] cyt during ATP treatment. The ATP-induced increase in [Ca 2ϩ ] cyt was reproducible (Fig. 5A ) and inhibited by pretreatment with suramin (100 M, data not shown). The response to UTP (1 M) was qualitatively and quantitatively indistinguishable from that to ATP (1 M) (Fig. 5B) . However, ADP (1 M) failed to elicit discernible changes in [Ca 2ϩ ] cyt , although higher concentration of ADP (10 M) induced a slight increase in [Ca 2ϩ ] cyt (Fig. 5C ). We found that 1 M UTP or ATP induced similar increases in [Ca 2ϩ ] cyt measured at 1 min after superfusion of nucleotides in Ca 2ϩ -containing solutions, but re- 
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P2Y MEDIATES Ca 2ϩ SIGNALING AND DMBS sponse to ADP was much smaller (Fig. 5D ). These data are consistent with our RT-PCR and duodenal epithelial ion transport data described above, indicating that P2Y 2 receptor is a major subtype of P2Y receptors functionally expressed in duodenal epithelial cells. (Fig. 6A) . Nifedipine (10 M), a voltage- (Fig.  6, D and E) . Figure 6F summarizes the effects of ATP on [Ca 2ϩ ] cyt measured at 1 min after the cells were exposed to ATP (1 M) in the absence or the presence of different inhibitors in Ca 2ϩ -containing solutions. In the case of Ca 2ϩ -free solutions, although ATP (1 M) also increased [Ca 2ϩ ] cyt , the response was transient and followed by rapid decline to the baseline level before withdrawal of ATP (n ϭ 50 cells, data for ATP not shown here, but similar data for UTP are shown in Fig. 7 -dependent biological processes in epithelial cells (7, 21, 48) . We thus examined whether SOC is functionally expressed and whether CCE is involved in P2Y-mediated [Ca 2ϩ ] cyt in duodenal epithelial cells by assessing response to UTP.
ATP-induced intracellular
] cyt transient in Ca 2ϩ -free solutions (Fig. 7A) . Restoration of external Ca 2ϩ (2 mM) ϳ5 min after [Ca 2ϩ ] cyt transients declined back to the basal level (i.e., when the store was depleted) increased [Ca 2ϩ ] cyt due to Ca 2ϩ entry (Fig. 7A) . Nifedipine (10 M) was applied throughout the experiments to prevent the involvement of VGCC. Pretreatment of cells with 2-APB (10 M), a cellpermeable antagonist of IP 3 receptor and SOC blocker, partially inhibited UTP-induced intracellular Ca 2ϩ release and abolished CCE through SOC (Fig. 7B) . La 3ϩ (30 M), a nonselective SOC blocker that does not alter UTP-induced intracellular Ca 2ϩ release, abolished UTP-induced CCE (Fig.  7C) . Similarly, SK&F96365 (30 M), a selective SOC blocker, abolished UTP-induced CCE in duodenocytes (Fig. 7D) . Figure 7E summarizes the effects of La 3ϩ , SK&F96365, and 2-APB on UTP-induced intracellular Ca 2ϩ release, which was significantly inhibited only by 2-APB (59%). However, La 3ϩ , SK&F96365, and 2-APB significantly inhibited CCE by 92, 87, and 94%, respectively (Fig. 7F) . Thus SOC likely plays an 
DISCUSSION
Epithelial cells can release nucleotides (such as ATP/UTP) in response to physiological stimuli, including changes in cell volume, membrane stress, and receptor stimulation (8, 33, 36, 38, 43, 55) . In the intestinal tract, stimuli, such as ingestion of food and water, can readily evoke ATP/UTP release from epithelial cells (23, 55). Purinergic receptors are expressed in epithelial cells and induce a variety of biological effects (1). Three rodent P2Y receptors are sensitive to UTP: P2Y 2 , P2Y 4 , and P2Y 6 (52); however, P2Y 2 and P2Y 4 , but not P2Y 6 , are sensitive to suramin (1, 52) . P2Y 2 and P2Y 4 receptors can couple to G q/11 proteins and activate PLC-␤, resulting in production of IP 3 and mobilization of intracellular Ca 2ϩ . P2Y 2 receptors, a prominent subtype of luminal P2Y receptors in many epithelia, respond to agonists with the order of potency UTP ϭ ATP Ͼ ADP and are inhibited by suramin and PPADS (1, 6, 10) .
Purinergic signaling pathways contribute to the regulation of ion transport in intestinal, biliary, and pancreatic duct epithelium (14, 24, 32, 39, 40) . However, little is known regarding the expression and function of the P2Y receptors in duodenal epithelium; only one report has implied that endogenous luminal ATP released from duodenal brush border is involved in DMBS (2) . In the present study, we show that mRNAs of the P2Y receptors are expressed in duodenal epithelial cells and that P2Y 2 is a major subtype. Furthermore, we used UTP as a selective P2Y receptor agonist (13, 52) in studies with Ussing chambers to demonstrate that P2Y receptor activation stimulates duodenal I sc and DMBS. UTP stimulated duodenal I sc and DMBS over a similar time course, with effects lasting at least 30 min. Mucosal or serosal addition of UTP induced comparable effects on duodenal HCO 3 Ϫ secretion, suggesting that functional P2Y receptors are expressed on both the luminal and the basolateral membranes of duodenal epithelial cells, results akin to those found for other epithelial cells (24, 39, 46) . The stimulatory effect of UTP was significantly inhibited by use of a P2Y-receptor antagonist or a SOC blocker. Responses to ATP are potentially mediated by numerous types of P2X and P2Y receptors or by its degradation to adenosine and the activation of the adenosine (P1) receptors (10), but activation by UTP can only be readily attributable to the activation of P2Y receptors.
To assess if P2Y receptors have physiological roles in the regulation of DMBS, we used HCl as a physiological stimulus in animals and found that acid-stimulated DMBS was attenuated similarly by two P2Y-receptor antagonists with different chemical structures. We assessed P2Y-receptor-mediated DMBS by using two different techniques to measure HCO 3 Ϫ , i.e., pH-stat method in vitro (Figs. 2 and 3 ) and CO 2 -sensitive electrodes in vivo (Fig. 4) . The pH-stat method detects a loss of H ϩ or increase in HCO 3
Ϫ
, and thus its use can be confounded by epithelial H ϩ secretion. However, CO 2 -sensitive electrodes measure HCO 3 Ϫ concentration (22). The rates of duodenal HCO 3 Ϫ in vitro seem lower than those observed in mice in vivo (Fig. 3 vs. Fig. 4 3 Ϫ secretion. Importantly, we confirmed a role for P2Y 2 -mediated DMBS by use of a genetic approach: UTP-stimulated HCO 3 Ϫ secretion was markedly impaired in P2Y 2 knockout mice (Fig. 4B) . Taken together, our data not only support the idea that extracellular ATP can regulate DMBS (2), but also provide strong evidence for the expression of P2Y 2 subtype in duodenal epithelial cells and for a key role of P2Y 2 receptors in purinergic regulation of DMBS.
Both ATP and UTP can mobilize [Ca 2ϩ ] cyt via activation of the P2Y receptors in many types of mammalian cells (32, 39, 40, 49, 64) . To assess such an activity in duodenal epithelial cells, we used the SCBN cell model because of the following. 1) This cell line is a well-characterized, nontransformed duodenal epithelial crypt cell line, which forms electrically tight monolayers (45) .
2) It expresses functional CFTR channels and has been used in the study of Ca 2ϩ -dependent Cl Ϫ secretion (11, 12) . 3) Activation of protease-activated receptor can stimulate HCO 3 Ϫ secretion in SCBN cells (unpublished observations), results that are in agreement with the report of Buresi et al. (12) regarding a residual increase in I sc in Cl Ϫ -free solution that was likely due to HCO 3 Ϫ transport evoked by activation of protease-activated receptor in these cells. 4) P2Y 2 receptors are expressed in both mouse duodenal epithelium and SCBN cells (Fig. 1) . All of these features made SCBN a valuable cell model for the present study and potentially for future studies as well.
Our data show that UTP and ATP, but not ADP, were similarly effective in increasing Ca 2ϩ signaling in SCBN cells, consistent with the expression of P2Y 2 receptors in these cells (1, 6, 10 (34, 35, 40, 58) .
Although the molecular mechanism of CCE is not fully understood, two proteins (Stim1 and Orai proteins) appear to (26, 63) .
Although defining the precise role of purinergic pathways in regulating intestinal epithelial ion transport will require further investigation, the present findings imply that studies of P2Y, in particular P2Y 2 receptor, pathways are a potentially promising target for the treatment of pathological conditions in the intestinal tract, including perhaps protection from acid-induced duodenal injury (3, 4, 31) . Increased understanding of the cellular and molecular mechanisms of Ca 2ϩ -mediated DMBS via activation of P2Y (e.g., P2Y 2 ) receptors thus has physiological and potential clinical significance. 
